Close Menu
Invest Insider News
    Facebook X (Twitter) Instagram
    Friday, November 20
    Facebook X (Twitter) Instagram Pinterest Vimeo
    Invest Insider News
    • Home
    • Bitcoin
    • Commodities
    • Finance
    • Investing
    • Property
    • Stock Market
    • Utilities
    Invest Insider News
    Home»Stock Market»Stock Market Today, April 29: KalVista Pharmaceuticals Surges on Chiesi Group Acquisition Announcement
    Stock Market

    Stock Market Today, April 29: KalVista Pharmaceuticals Surges on Chiesi Group Acquisition Announcement

    April 29, 20262 Mins Read


    KalVista Pharmaceuticals Stock Quote

    Today’s Change

    (38.62%) $7.43

    Current Price

    $26.67

    Key Data Points

    Market Cap

    $986M

    Day’s Range

    $26.66 – $26.76

    52wk Range

    $9.83 – $26.76

    Volume

    71M

    Avg Vol

    979K

    Gross Margin

    -932.68%

    KalVista Pharmaceuticals (KALV +38.62%), a developer of oral therapies for rare diseases, closed Wednesday at $26.67, up 38.62%. The stock moved higher after news that Italy’s Chiesi Group will acquire KalVista for $27 per share in cash. Investors are watching deal closing risks and regulatory approvals. Trading volume reached 69.4 million shares, about 3,323% above its three-month average of 2 million shares. KalVista Pharmaceuticals IPO’d in 2015 and has fallen 66% since going public.

    How the markets moved today

    The S&P 500 slipped 0.02% to finish Wednesday at 7,138, while the Nasdaq Composite inched up 0.04% to close at 24,673. Within the biotechnology sector, rivals were mixed, with Prothena closing at $10.87, down 5.56%, as investors reassessed risk around drug pipelines and deal activity.

    What this means for investors

    KalVista Pharmaceuticals’ stock is pricing in a high likelihood that the company will be taken private by Italy’s Chiesi Group at $27 per share, after its share price spiked 39% today to $26.67. Home to EKTERLY, an oral medicine for hereditary angioedema, which affects 1 in 50,000 people, KalVista’s addition to Chiesi will round out the latter’s portfolio of rare disease treatments.

    The acquisition is interesting to me because KalVista was previously one of the most-shorted stocks on the market, with 40% short interest. With EKTERLY only recently being approved in July 2025 — and KalVista only reporting three quarters of revenue from the treatment — Chiesi’s larger, international scale should help the nascent treatment option reach more potential patients.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleBitcoin Drops Under $75K After Fed Decides To Hold Rates: Will Bulls Buy?
    Next Article Hyperscaler results pose major test for AI-driven US stock market

    Related Posts

    Stock Market

    Is Comfort Systems USA Stock Increasing Your Market Risk?

    November 20, 2026
    Stock Market

    Japan’s SoftBank Plunges Over 16% Intraday, Leading Asian Stock Sell-Off

    November 20, 2026
    Stock Market

    BNY ETF ICAV publishes NAVs for five bond ETFs on London Stock Exchange

    November 20, 2026
    Leave A Reply Cancel Reply

    Top Posts

    How is the UK Commercial Property Market Performing?

    December 31, 2000

    How much are they in different states across the US?

    December 31, 2000

    A Guide To Becoming A Property Developer

    December 31, 2000
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews
    Utilities

    As Debby moves through the Tri-state; utilities and charities expect the worst

    August 9, 2024
    Bitcoin

    This Week in Coins: Bitcoin Dips, Ethereum Sits Still as Trump Family Settles In

    August 17, 2024
    Utilities

    Down 12%, this FTSE utilities provider is 31% under its ‘fair value’ and has a forecast dividend yield of 6.5%!

    September 10, 2025
    What's Hot

    LLY Stock Too Cheap At $750?

    June 3, 2025

    Stock recommendations for 30 October from MarketSmith India

    October 29, 2025

    Dow closes at record high on hopes of Republican sweep in November

    July 15, 2024
    Most Popular

    Blog: The green premium – fact or fiction in UK property valuation? – Mortgage Finance Gazette

    July 10, 2025

    UK gambling stocks surge on U.S. bill to ban sports bets on prediction markets By Investing.com

    March 23, 2026

    Fairbanks City Council to revisit postponed property ordinances | Local News

    August 23, 2024
    Editor's Picks

    repenser la finance mondiale au service de l’humain – La Presse de Tunisie

    June 29, 2025

    See which states has the highest property tax rates, lowest in the US

    March 14, 2025

    How Mamdani’s Price Controls Could Skew CPI Data

    November 5, 2025
    Facebook X (Twitter) Instagram Pinterest Vimeo
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions
    © 2026 Invest Insider News

    Type above and press Enter to search. Press Esc to cancel.